Clinical Trial Update: NIR Hypoxia Imaging of Breast Tumor Response to Neoadjuvant Chemotherapy in Vivo

View source ↗

Summary

A clinical trial evaluating near-infrared hypoxia imaging to assess breast tumor response to neoadjuvant chemotherapy has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Dartmouth-Hitchcock Medical Center | Conditions: Breast Cancer | Status: TERMINATED